Công ty cổ phần Dược phẩm La Fon Việt Nam

Một trang web mới sử dụng WordPress

hotline

Hotline

0989 748 120
  • Trang chủ
  • Giới thiệu
  • Sản phẩm
  • Tin tức
    • Tin nội bộ
    • Tin y dược
    • Chuyên đề sức khỏe
  • Tuyển dụng
  • Hỏi đáp
  • Liên hệ
Trang chủ » Blog

Prostate pill may help halt female hair loss and cause ‘significant’ growth, study shows

A drug used to treat prostate cancer may help women combat hair loss. In a recent study of 17 women, more than half experienced ‘significant’ hair regrowth within weeks of taking the drug, bicalutamide.

The treatment works for prostate cancer by stopping testosterone from reaching cancer cells. 

Prostate cancer uses the male hormone to grow, and blocking it not only slows the growth of a tumour, it may even shrink it. It is these same testosterone-blocking effects that prompted scientists to trial the drug for female hair loss.

A drug used to treat prostate cancer may help women combat hair loss

That’s because, along with genetics and the menopause, for example, the hormone is implicated in androgenetic alopecia, the most common form of hair loss in women.

Testosterone, while regarded as a male hormone, is also present in small quantities in women, and can attack hair follicles and accelerate hair loss in women.

This process accelerates post-menopause as when women’s oestrogen levels decline, the testosterone becomes more dominant.

As a result, hairs produced by the affected follicles become progressively smaller in diameter and shorter in length until eventually the follicles shrink completely and stop producing hair.

Typically this results in an overall thinning of the hair.

It’s thought to affect up to one in three women at some time, and has been linked to an increased risk of depression. It starts later in life than hair loss in men, with symptoms commonly appearing in the patient’s 50s or 60s.

Current treatments include the drug minoxidil, but this won’t work for all and brings the risk of side-effects such as skin rashes and headaches.

In the new trial, bicalutamide, taken as a pill, was given to the women every day, or every other day for a minimum of six months. According to the results of the pilot study reported in the journal, Dermatologic Therapy, there was a ‘great improvement’ in hair density in 53 per cent of the women.

The results were based on visual before and after assessments by dermatologists.

There were no ‘significant’ adverse events, but in cancer patients it can cause rashes and hot sweats.

The researchers behind the trial, from Ramon y Cajal University Hospital in Madrid, believe their results show: ‘Treatment with this drug may be a new and useful option for women.’

Commenting on the research, Dr Bav Shergill, a consultant dermatologist, and honorary senior lecturer, at the University of Manchester, says similar anti-testosterone drugs such as spironolactone have shown promise too, adding: ‘This new application of a prostate cancer drug is interesting and I look forward to seeing research on a larger group.

In the new trial, bicalutamide, taken as a pill, was given to the women every day, or every other day for a minimum of six months. According to the results of the pilot study reported in the journal, Dermatologic Therapy, there was a ‘great improvement’ in hair density in 53 per cent of the women.

The results were based on visual before and after assessments by dermatologists.

There were no ‘significant’ adverse events, but in cancer patients it can cause rashes and hot sweats.

The researchers behind the trial, from Ramon y Cajal University Hospital in Madrid, believe their results show: ‘Treatment with this drug may be a new and useful option for women.’

Commenting on the research, Dr Bav Shergill, a consultant dermatologist, and honorary senior lecturer, at the University of Manchester, says similar anti-testosterone drugs such as spironolactone have shown promise too, adding: ‘This new application of a prostate cancer drug is interesting and I look forward to seeing research on a larger group.’

Chia sẻ

Bài viết liên quan

  • Dùng thuốc ho đúng cách để trị bệnh hiệu quả

  • Thuốc nào gây hại dạ dày?

  • Nên uống canxi vào thời điểm nào?

  • To battle opioid crisis, Google is partnering with gov’t, big pharma to help

  • Under pressure: how stress can change our lives for the better

Danh mục
  • Tin nội bộ
  • Tin y dược
  • Chuyên đề sức khỏe

Tin mới nhất

La Fon thông báo nghỉ lễ Quốc Khánh 2/9

La Fon thông báo nghỉ lễ Quốc Khánh 2/9

Bộ trưởng Nguyễn Thanh Long: Bộ Y tế nỗ lực đàm phán, trao đổi hơn 200 cuộc để có 130 triệu liều vắc xin phòng COVID-19.

Bộ trưởng Nguyễn Thanh Long: Bộ Y tế nỗ lực đàm phán, trao đổi hơn 200 cuộc để có 130 triệu liều vắc xin phòng COVID-19.

La Fon thông báo lịch nghỉ lễ Giỗ tổ Hùng Vương và 30/4 & 1/5

La Fon thông báo lịch nghỉ lễ Giỗ tổ Hùng Vương và 30/4 & 1/5

Tuyển dụng thiết kế full time

Tuyển dụng thiết kế full time

Tin nổi bật

Bày mẹ bí quyết cải thiện tình trạng hăm tã ở trẻ

Bày mẹ bí quyết cải thiện tình trạng hăm tã ở trẻ

Vì sao nên sử dụng Sâm nhung bổ thận Lion 30

Vì sao nên sử dụng Sâm nhung bổ thận Lion 30

Dược phẩm La Fon Việt Nam

Số ĐKKD 0101858531 do Sở KHĐT Tp. Hà Nội cấp ngày 03/01/2006

Địa chỉ:

số 21A, Lô 1, KĐT Đền Lừ 1, Quận Hoàng Mai, Hà Nội |

Email: info@lafonpharma.vn

Hotline: 0989748120

Hướng dẫn mua hàng

Chính sách mua hàng và thanh toán

Chính sách bảo hành và đổi trả

Chính sách bảo mật thông tin

Thông tin về vận chuyển và giao nhận

Fanpage

Copyright © 2021 Lafonpharma.vn All rights reserved